Cite
Boieri M, Ulvmoen A, Sudworth A, et al. IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development . Oncoimmunology. 2017;6(3):e1274478doi: 10.1080/2162402X.2016.1274478.
Boieri, M., Ulvmoen, A., Sudworth, A., Lendrem, C., Collin, M., Dickinson, A. M., Kveberg, L., & Inngjerdingen, M. (2017). IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development . Oncoimmunology, 6(3), e1274478. https://doi.org/10.1080/2162402X.2016.1274478
Boieri, Margherita, et al. "IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development ." Oncoimmunology vol. 6,3 (2017): e1274478. doi: https://doi.org/10.1080/2162402X.2016.1274478
Boieri M, Ulvmoen A, Sudworth A, Lendrem C, Collin M, Dickinson AM, Kveberg L, Inngjerdingen M. IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development . Oncoimmunology. 2017 Jan 17;6(3):e1274478. doi: 10.1080/2162402X.2016.1274478. eCollection 2017. PMID: 28405496; PMCID: PMC5384344.
Copy
Download .nbib